Delivery Order SPE2DB22D1200-SPE2DB25FN0NT

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,138.65, is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,619.51, is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $2,605.55 and a period of performance through July 9, 2024. The contract is a Firm Fixed Price vehicle, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,204.80 firm-fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a completion date of November 17, 2022 and was awarded on November 16, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $3,485.70 and a performance period through March 3, 2025. The contract is a firm fixed-price type and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.65 contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a type of pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 5, 2024. The award is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,837.87 firm fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 8, 2024. This delivery order is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,026.76, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2024. The contract was not designated with a set-aside requirement, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,703.26, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through May 2, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM medical supplies, with a ceiling value of $9,023.54 and a completion date of June 14, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB25FN0NT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,820.60, is for the provision of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price contract. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:08 AM